Navigation Links
Cordex Pharma Sets Fourth Quarter 2008 Program Update Call
Date:2/13/2009

ard-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Cordex intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Cordex are forward-looking statements, including, but not limited to, the statements regarding ATPace's expected entry into a pivotal Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, and CDP-1050's expected commencement of a Phase 2 clinical trial for the treatment of heart failure. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Such risks include the risk that the clinical trial for approval of ATPace and the Phase 2 clinical trial for our CDP-1050 may not be successful, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be successful, and that our technology may not lead to expected results including the development or the successful commercialization of technologies relating to the use of ATP or nitric oxide. Additional uncertainties and risks are described in Cordex's most recently filed SEC documents, such as
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
2. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
3. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
4. URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
5. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
6. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results
7. Managing Myeloma (www.managingmyeloma.com) Launches - A Comprehensive Information and Educational Site for Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists
8. Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
9. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
10. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
11. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... 20, 2013 Eric Shuman knows a little ... trip at a Travel Services function to show support of ... company. , Having been in the Travel Business and Timeshare ... vacations was unsurpassed. Now, a year after he's done, he ... Club to a group of private investors for 36 million ...
(Date:6/20/2013)... San Francisco, CA (PRWEB) June 20, 2013 ... medical experts to expect nothing more than days that would ... life? , Holly Reese chose her own way. , ... and out of Chronic Illness," describes her complicated and emotional ... called Mixed Connective Tissue Disorder. Reese submits to the harsh ...
(Date:6/20/2013)... and Cincinnati, Ohio (PRWEB) June 20, 2013 ... announced a partnership that will dramatically improve the ... joint LIT-WorkFlex offering enables call center operators to ... which can result in agent long-term knowledge retention ... a hands-on, interactive, multi-modal learning methodology that addresses ...
(Date:6/20/2013)... 20, 2013 Dallas-based TopMD™ Skin Care, ... the launch of its newest product, CLn® Facial ... with sensitive skin conditions in mind. CLn Facial Cleanser, ... Acceptance, repairs the skin’s moisture barrier and minimizes tightness, ... are excited to enter the facial cleanser realm with ...
(Date:6/20/2013)... Dr. Julie Prutsman of Sound Relief ... and tinnitus services, has released five tips for ... summer recreation. Summer is the loudest season and typical ... concert or motorcycling can be potentially damaging to the ears. ... hearing protection can prevent permanent damage from the loud sounds ...
Breaking Medicine News(10 mins):Health News:As a Show of Support to New Ownership at a Member Function, Former Owner of Travel Services Center, Eric Shuman Books Travel with His Previous Company 2Health News:Author and Survivor Holly Reese Explains Why Western Medicine Isn’t Enough 2Health News:LIT OnLine Partners with WorkFlex Solutions to Revolutionize Online Call Center Training 2Health News:TopMD™ Announces Launch of CLn® Facial Cleanser 2Health News:Summer Recreation Yields High Risk for Ear Damage among Both Children and Adults 2Health News:Summer Recreation Yields High Risk for Ear Damage among Both Children and Adults 3
... Blank Family,Foundation today announced it is awarding $100,000 ... Foundation to fund a,comprehensive study that will explore ... Georgia,s Pre-K enrollment rates have stalled at around ... In order to improve outcomes for,children, high quality ...
... WEST LAFAYETTE, Ind. - A Purdue University researcher is working ... way that more accurately reflects real-world situations. , "The traditional ... is to put them in a quiet room and ask ... see," said Karen Iler Kirk, a professor of speech, language ...
... Healthcare, AFL-CIO Secretary Treasurer Richard Trumka to Keynote Canadian, ... ... First Responders to Join Emotional September 11th Rally With a,Plea ... OAKLAND, Calif., Sept. 6 The California Nurses,Association/National Nurses ...
... Women,s ... Cancer Research Fund, MONTVALE, N.J., Sept. ... its all-new, eagerly-awaited 2008,C350 Sport Sedan to raise funds for Saks ... partnership with the Entertainment,Industry Foundation,s (EIF) Women,s Cancer Research Fund. As ...
... of Emergency Medicine will participate in a nationwide study ... increasingly common, antibiotic-resistant infection. , The objective of ... for otherwise healthy people who have MRSA, said David ... the School of Medicine and Hospital, who will lead ...
... & Diamonds: An Evening with Tim McGraw and Friends, ... Presented by Anheuser-Busch Companies, ... its third annual fundraising gala on Friday, Nov. 2 at ... St. Louis. Anheuser-Busch,Companies is sponsoring "Denim & Diamonds: An Evening ...
Cached Medicine News:Health News:The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia 2Health News:Researcher developing new method for hearing loss assessment 2Health News:Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention 2Health News:Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenue's KEY TO THE CURE 2Health News:Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenue's KEY TO THE CURE 3Health News:Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenue's KEY TO THE CURE 4Health News:Temple Emergency Medicine receives $1.8M to find best MRSA treatment 2Health News:Temple Emergency Medicine receives $1.8M to find best MRSA treatment 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 4
(Date:6/20/2013)... -- SurgiQuest, Inc. ("SurgiQuest", the "Company") today announced that ... President and Chief Commercialization Officer. Prior to his arrival ... North America , of Smith & Nephew Wound ... Vice President of Sales and Marketing at Sonosite from ... of Datascope from 2002 to 2004. After starting his ...
(Date:6/20/2013)... June 20, 2013  Elekta claimed the top two ... 2013 Best in KLAS Awards: Medical Equipment & Infrastructure ... and Elekta Infinity™ radiation therapy system earned the #1 ... year in which Perfexion has won the Best in ... report, Perfexion scored 92.9 out of 100, and 96 ...
(Date:6/20/2013)... BALTIMORE , June 20, 2013  A new ... pain medication monitoring, revealed that more than one-third (35.9 ... for chronic pain management last year did not contain ... found in similar research released in October 2010. ... Ameritox analyzed samples from more than half a million ...
Breaking Medicine Technology:Tom Dugan Joins SurgiQuest, Inc. as President and Chief Commercialization Officer 2Elekta's Leksell Gamma Knife Perfexion Earns Top Rank in 2013's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion Earns Top Rank in 2013's Best in KLAS for Radiation Therapy 3New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples 2New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples 3
... billion into 662 deals for U.S.-based companies during the third quarter ... in deals from the same period last year, according to Dow ... $18 billion was put into 2,016 deals during the first three ... activity over the same period last year. "The uptick ...
... (Soligenix or the Company) (OTC Bulletin Board: ... reported preliminary results from its Phase 2 "proof-of-concept" ... of acute Graft-versus-Host disease (GVHD) in patients undergoing ... to hematopoietic cell transplantation (HCT) and continuing through ...
Cached Medicine Technology:U.S. Venture Investment in 2010 Tracks Ahead of Last Year 2U.S. Venture Investment in 2010 Tracks Ahead of Last Year 3Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 2Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 3Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 4Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 5Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 6Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 7Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD 8
The cath lab blanket, designed for use in the Cardiac Cath Lab, surrounds the patient with warm air and allows unrestricted access to the femoral artery....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The full body surgical blanket is designed for procedures on the head and neck. This lightweight blanket tapes across the patient's chest, away from surgical sites involving the head or neck....
Medicine Products: